← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystalePPD Development, LPPhase 2

Cohort A: vilobelimab (Cohort A: vilobelimab)

Acute Respiratory Distress Syndrome (ARDS); ARDS · Acute Respiratory Distress Syndrome (ARD

#AcuteRespiratoryDistressSyndrome#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMichael DonahoePhase 2

Combined Plasma Exchange (PEX, Combined Plasma Exchange, Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids)

IPF · IPF

#IPF#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleBaptist Health South FloridaPhase 1

trastuzumab (Herceptin, Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Brain Metastases; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleMedical College of WisconsinPhase 1

atezolizumab (Tecentriq, Concurrent Atezolizumab)

Head and Neck Neoplasm · Head and Neck Neoplasm

#HeadandNeckNeoplasm#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversitätsklinikum KölnPhase 2

Nivolumab/Ipilimumab (Concurrent Chemo-radio-immunotherapy, Concurrent Chemo-radio-immunotherapy (Nivolumab/Ipilimumab))

Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases · Cervical Cancer ≥ FIGO IIB and or Lymph

#CervicalCancerFIGOIIBandorLymph#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleIdris BahceApproved

durvalumab (Imfinzi, Consolidation durvalumab)

Non-small Cell Lung Cancer Stage III · Non-small Cell Lung Cancer Stage III

#Non-smallCellLungCancerStageIII#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleUniversity of Texas Southwester…Phase 2

durvalumab (Imfinzi, Consolidative Durvalumab)

Non Small Cell Lung Cancer; Lung Cancer Stage III · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleCity of Hope Medical CenterPhase 1

pembrolizumab (Keytruda, Copper Cu 64-DOTA-pembrolizumab)

Metastatic Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm

#MetastaticMalignantSolidNeoplasm#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNovartisPhase 1

Cosentyx（Secukinumab ） (Cosentyx（Secukinumab ）)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleNovartis PharmaceuticalsPhase 3

Crizanlizumab (Crizanlizumab)

Sickle Cell Disease · Sickle Cell Disease

#SickleCellDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleFudan UniversityPhase 2

Cromolyn, TQB2102, and Panpulimab (Cromolyn, TQB2102, and Panpulimab)

Triple -Negative Breast Cancer · Triple -Negative Breast Cancer

#Triple-NegativeBreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Cryoablation Combined with Tirelizumab and Bevacizumab (Cryoablation Combined with Tirelizumab and Bevacizumab)

Metastatic Breast Cancer in the Liver · Metastatic Breast Cancer in the Liver

#MetastaticBreastCancerintheLiver#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, Cyclo Thal Dex Daratumumab)

Multiple Myeloma Stage I · Multiple Myeloma Stage I

#MultipleMyelomaStageI#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMedical College of WisconsinPhase 3

Cyclophosphamide and Rituximab (Cyclophosphamide and Rituximab)

Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma · Recurrent Grade 1 Follicular Lymphoma

#RecurrentGrade1FollicularLymphom#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleHeidelberg UniversityPhase 2

Cyclophosphamide, Pentostatin, Rituximab (Cyclophosphamide, Pentostatin, Rituximab)

Immunocytoma/Morbus Waldenström; B-Cell Non-Hodgkin's Lymphoma · Immunocytoma/Morbus Waldenström

#ImmunocytomaMorbusWaldenstrm#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

Cyclophosphamide, Topotecan, and Bevacizumab (Cyclophosphamide, Topotecan, and Bevacizumab)

Neuroblastoma; Sarcoma · Neuroblastoma

#Neuroblastoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleZeneus PharmaPhase 2

R-COMP (Cyclophosphamide, oncovin, myocet, prednisone & rituximab, Cyclophosphamide, oncovin, myocet, prednisone & rituximab (R-COMP))

Aggressive Non-Hodgkin's Lymphoma in the Elderly. · Aggressive Non-Hodgkin's Lymphoma in the

#AggressiveNon-HodgkinsLymphomain#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleScripps HealthPreclinical

Cyclophosphamide/Rituximab (Cyclophosphamide/Rituximab)

Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Relapsing-Remitting

#MultipleSclerosisRelapsing-Remit#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleDong-A ST Co., Ltd.Phase 2

pembrolizumab (Keytruda, DA-4505 + Pembrolizumab)

Locally Advanced or Metastatic Solid Tumors · Locally Advanced or Metastatic Solid Tum

#LocallyAdvancedorMetastaticSolid#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

37 / 92 페이지

← 이전다음 →